BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22972438)

  • 1. Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells.
    Wang L; Huang T; Chen W; Gao X; Zhou T; Wu Z; Sun Y
    Oncol Rep; 2012 Dec; 28(6):2043-8. PubMed ID: 22972438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
    Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
    Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
    Pan J; Mestas J; Burdick MD; Phillips RJ; Thomas GV; Reckamp K; Belperio JA; Strieter RM
    Mol Cancer; 2006 Nov; 5():56. PubMed ID: 17083723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
    Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
    Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of short hairpin RNA-induced CXCR4 silence on ovarian cancer cell.
    Chen HY; Wang JM; Wang HY; Zhang YX; Liu W; Pan L; Wang WH; Chen SF; Jin WG; Wang L
    Biomed Pharmacother; 2012 Oct; 66(7):549-53. PubMed ID: 22902648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells.
    Zhang Y; Chen ZD; Du CJ; Xu G; Luo W
    Pathol Res Pract; 2009; 205(12):823-7. PubMed ID: 19628339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H; Mansel RE; Jiang WG
    Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells].
    Du YF; Xing YF; Zeng FQ; Lu P; Liu XY; Xiao YJ
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):489-94. PubMed ID: 18069626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of CXCR4 inhibited by RNA interference on metastasis and invasion of breast cancer cell in vitro].
    Zhang SC; Qiao L; Gao H
    Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):473-5. PubMed ID: 17686306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo.
    Lapteva N; Yang AG; Sanders DE; Strube RW; Chen SY
    Cancer Gene Ther; 2005 Jan; 12(1):84-9. PubMed ID: 15472715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.
    Sutton A; Friand V; Brulé-Donneger S; Chaigneau T; Ziol M; Sainte-Catherine O; Poiré A; Saffar L; Kraemer M; Vassy J; Nahon P; Salzmann JL; Gattegno L; Charnaux N
    Mol Cancer Res; 2007 Jan; 5(1):21-33. PubMed ID: 17259344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α.
    Oh YS; Kim HY; Song IC; Yun HJ; Jo DY; Kim S; Lee HJ
    Oncol Rep; 2012 Dec; 28(6):2239-46. PubMed ID: 23023480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis.
    Tang CH; Tan TW; Fu WM; Yang RS
    Carcinogenesis; 2008 Jan; 29(1):35-43. PubMed ID: 17916907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
    Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
    Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
    Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].
    Zhang MX; Han N; Yu SY; Leng Y
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice.
    Wang Q; Wang S; Sun SQ; Cheng ZH; Zhang Y; Chen G; Gu M; Yao HJ; Wang Z; Zhou J; Peng YB; Xu MX; Zhang K; Sun XW
    Cancer Biomark; 2016; 16(1):1-9. PubMed ID: 26484606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
    Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
    Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
    Wu D; Pan H; Zhou Y; Zhou J; Fan Y; Qu P
    Mol Med Rep; 2014 Jun; 9(6):2491-8. PubMed ID: 24714873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.